Literature DB >> 856676

Effect of aspirin on intestinal absorption of glucose, sodium, and water in man.

C Arvanitakis, G H Chen, J Folscroft, N J Greenberger.   

Abstract

The effect of aspirin on small intestinal function in six healthy volunteers was examined using a segmental perfusion technique, with a test solution of 40 mM D-glucose, 140 mM NaCl, and 0-5% polyethylene glycol. Jejunal glucose, sodium, and water absorption rates were inhibited by 50% after oral administration of 2-6 g aspirin. Adenosine triphosphate (ATP) concentration was assayed in jejunal mucosal biopsies before and after aspirin. There was an almost 50% decrease in mucosal ATP levels after aspirin. This effect may be mediated through cellular injury and impairment of mitochondrial energy metabolism. These data suggest that aspirin may significantly alter small intestinal function. It appears possible that the inhibitory effect of aspirin on glucose absorption may account, at least in part, for the lower blood sugar levels observed with the use of the drug.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856676      PMCID: PMC1411388          DOI: 10.1136/gut.18.3.187

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  STUDIES OF AN INHIBITOR OF THE TWO ANTIBODY IMMUNOASSAY SYSTEM.

Authors:  C R MORGAN; R L SORENSON; A LAZAROW
Journal:  Diabetes       Date:  1964 Jan-Feb       Impact factor: 9.461

2.  INHIBITION OF RAT BRAIN GLUTAMATE DECARBOXYLASE ACTIVITY BY SALICYLATE IN VITRO.

Authors:  B J GOULD; M J SMITH
Journal:  J Pharm Pharmacol       Date:  1965-01       Impact factor: 3.765

3.  A multipurpose instrument for suction biopsy of the esophagus, stomach, small bowel, and colon.

Authors:  L L BRANDBORG; G E RUBIN; W E QUINTON
Journal:  Gastroenterology       Date:  1959-07       Impact factor: 22.682

4.  Reappraisal of the hypoglycemic action of acetylsalicylate.

Authors:  A HECHT; M G GOLDNER
Journal:  Metabolism       Date:  1959-07-01       Impact factor: 8.694

5.  The insulin equivalence of salicylate.

Authors:  J REID; T D LIGHTBODY
Journal:  Br Med J       Date:  1959-04-04

6.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

7.  The uncoupling of oxidative phosphorylation as a mechanism of drug action.

Authors:  T M BRODY
Journal:  Pharmacol Rev       Date:  1955-09       Impact factor: 25.468

8.  Rapid determination of salicylate in biological fluids.

Authors:  P TRINDER
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

9.  Determination of ATP and related compounds: firefly luminescence and other methods.

Authors:  B L STREHLER; J R TOTTER
Journal:  Methods Biochem Anal       Date:  1954

10.  The effect of salicylate on glycosuria, blood glucose and liver glycogen of the alloxan-diabetic rat.

Authors:  M J H SMITH; B W MEADE
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

View more
  5 in total

Review 1.  Drug-induced diarrhoea.

Authors:  O Chassany; A Michaux; J F Bergmann
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

2.  Effect of alpha-glucosidehydrolase inhibition and intestinal absorption of sucrose, water, and sodium in man.

Authors:  W F Caspary; H Kalisch
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

3.  High dose of aspirin moderates diabetes-induced changes of heart glycogen/glucose metabolism in rats.

Authors:  M Dervisevik; Suzana Dinevska-Kovkarovska; M Dimitrovska; N Cipanovska; B Miova
Journal:  J Physiol Sci       Date:  2014-09-03       Impact factor: 2.781

4.  Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.

Authors:  M E McAlindon; A F Muller; B Filipowicz; C J Hawkey
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

Review 5.  Antidiarrheal Drug Therapy.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2017-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.